Preclinical research involving mice suggests that very low doses of psilocybin could treat obesity, type 2 diabetes and fatty liver disease through a liver-based mechanism distinct from the compound’s psychedelic properties.
Within the past year, Green Dot Labs has pulled off both a major rebranding project and the Colorado-based company’s first... read more
Lucien moved to Boston from Haiti in 2002. She graduated from high school when she was 15 and eventually graduated... read more
More than 100 original works by local artists will be hidden in stores and throughout surrounding neighborhoods on March 12,... read more
Research involving over 130,000 people reveals genetic variants associated with brain signalling and impulsivity may also influence cannabis use patterns. read more
When Jeremy Berke left Business Insider at the end of 2022, he didn’t necessarily intend on launching his own media... read more
Sarah Spillman probably saw more of the United States than the average presidential candidate in 2024, traveling to dozens of... read more
Aaron Nosbisch has built Brēz into the industry’s leading beverage. Brēz was founded in February 2023, it brought in $28... read more
Only 35% of the general public think cannabis possession should remain a criminal offence, while one in three Brits say... read more
While overall cannabis sales revenue in Canada has seen some ups and downs over the past two years, one category... read more
Eric Latta took his first job in recreational cannabis at Buddy’s in Renton, Washington, in 2014. Eleven years later, he... read more
